Paediatric

07. February 2017 INTRODUCTION: The pharmacokinetics of excipients in neonates differs from that of older children. In a recent pan--European...

16. January 2017 Introduction Palatability of liquid medicines is a recognised challenge within the paediatric population Acceptability: “The overall ability...

16. January 2017 INTRODUCTION Dissolution of oral dosage forms depends on the GI tract physiological conditions, and definition of the...

03. January 2017 Abstract Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), is part of first-line therapy for the treatment...

24. August 2016 Pediatric Medicines Are Not Child’s Play! AAPS Blog Jennifer Walsh Since the introduction of pediatric regulations in the...

11. August 2016 Many pediatric patients require medications that are not available in age appropriate formulations, especially those with cardiovascular...

25. February 2016 The STEP stands for Safety and Toxicity of Excipients for Paediatrics. It is a user-designed resource developed by European Paediatric Formulation...

10. February 2016 The STEP stands for Safety and Toxicity of Excipients for Paediatrics. The STEP database is a user-designed...

26. September 2015 Why are excipients important to neonates? Abstract Neonates are given many medicines. A significant proportion of these...

  Palatability is one of the main (but not exclusive) pharmaceutical attribute of dosage forms which affect patient’s acceptability of...